Vext Science, Inc. Earnings Recaps
Q2 2026
Aug 22, 2026
Shares rose 4.2% following Q2 as margin expansion and successful execution on the Arizona cultivation exit and Ohio expansion outweighed flat revenue and earlier pricing missteps.
Key takeaways
- Revenue was $12.1 million, roughly flat sequentially but down 10% year-over-year, reflecting a planned pullback in Arizona wholesale.
- Gross margin improved substantially to 55% from 36% a year ago, driven by higher retail mix and better cultivation yields surpassing 100 grams per plant.
- Adjusted EBITDA increased for the second consecutive quarter, underscoring ongoing profitability progress despite top-line pressures.
- Ohio retail continues to drive growth including a new dispensary opened in June; however, a pricing error on flower in Ohio temporarily cost volume but has since been corrected.
- Arizona cultivation was wound down as planned amid declining state market sales and unattractive wholesale prices; focus shifted to third-party sourcing and operating two dispensaries, with customer traffic rebounding notably.
Q1 2026
May 22, 2026
Vext’s shares climbed modestly by 1.7% following its Q1 2026 earnings, reflecting a largely steady performance with improving profitability driven by Ohio operations offsetting ongoing headwinds in Arizona. The market reaction signals cautious approval but not enthusiasm, likely reflecting mixed contributions across regions and an ongoing margin focus.
Key takeaways
- Revenue rose 5% year-over-year to $12.2 million, led by a 34% increase in Ohio to $8.2 million, supported by new dispensaries and improved cultivation.
- Arizona revenue declined 24%, weighed down by oversupplied wholesale market and pricing pressure, with wholesale revenue down roughly 50% year-over-year.
- Gross profit more than doubled to $5.5 million, with a positive margin shift to 45.4%, driven by operating leverage and retail mix improvements in Ohio.
- Adjusted EBITDA increased to $3.6 million, or 29.3% margin, up from 15% last year, reflecting better profitability despite ongoing drag from Arizona.
- Cash from operations was $1.6 million despite temporary working capital challenges, with continued focus on Ohio expansion and planned completion of Arizona cultivation exit by end Q2.